34 results on '"Jaffe, Elaine S"'
Search Results
2. Reply to M. Romero et al
3. Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
4. Castleman disease spectrum.
5. Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
6. BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma
7. Uncommon Presentations of Malignancies: CASE 1. EXTRAOCULAR MUSCLE PALSIES IN SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA
8. Role of a Doxorubicin-Containing Regimen in Relapsed and Resistant Lymphomas: An 8-Year Follow-Up Study of EPOCH
9. Phase I Trial of Recombinant Immunotoxin Anti-Tac(Fv)-PE38 (LMB-2) in Patients With Hematologic Malignancies
10. New Malignant Diseases After Allogeneic Marrow Transplantation for Childhood Acute Leukemia
11. Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma.
12. The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH.
13. Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
14. Transformation of Follicular Lymphoma to Epstein-Barr Virus-Related Hodgkin-Like Lymphoma
15. Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project
16. Angioimmunoblastic T-Cell Lymphoma Partially Obscured by an Epstein-Barr Virus–Negative Clonal Plasma Cell Proliferation
17. Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
18. Association of idiotype vaccine-induced T-cell response with improved survival and time-to-next treatment (TTNT) in untreated mantle cell lymphoma (MCL).
19. Efficacy of alemtuzumab (ALZ) in combination with dose-adjusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma (PTCL).
20. Peripheral T-Cell Lymphoma With Aberrant Expression of CD30, CD15, and CD20
21. Successful Treatment of a Patient With Epstein-Barr Virus–Positive B-Cell Lymphoproliferative Disorder Resembling Post-Transplant Lymphoproliferative Disorder Using Single-Agent Rituximab
22. Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
23. Centralized Review Offers Promise for the Clinician, the Pathologist, and the Patient With Newly Diagnosed Lymphoma
24. Solitary Extramedullary Plasmacytoma of the Vocal Cord in an Adolescent
25. Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
26. Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers
27. In Reply
28. Identification of a Proliferation Signature Related to Survival in Nodal Peripheral T-Cell Lymphomas
29. Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression–Based Proliferation Signature
30. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
31. Increased Incidence of Hodgkin's Disease After Allogeneic Bone Marrow Transplantation
32. CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma
33. Diffuse Small Noncleaved-Cell, Non-Burkitt's Lymphoma in Adults
34. Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.